Literature DB >> 16720090

A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus.

T Junginger1, I Gockel, S Heckhoff.   

Abstract

AIM: The aim of this study was to investigate the long-term prognosis for squamous cell carcinoma of the esophagus treated either by the transhiatal (TH) or by the transthoracic (TT) operative approach. PATIENTS AND METHODS: Two hundred and twenty-nine patients (median age: 56 (29-84) years) with squamous cell carcinoma of the esophagus underwent esophageal resection between September 1985 and April 2004. In 70 patients, the transhiatal approach and in 159, the transthoracic approach was applied. An extended mediastinal lymph-node dissection was only carried out in the course of the transthoracic technique.
RESULTS: Demographic data and tumor stages were comparable in both groups. A significantly better long-term survival was observed in patients with transthoracic approach for those who had undergone curative procedures (R0) (24 versus 13 months), as well as for those either without (pN0) (38 versus 14 months) or with lymph-node involvement (pN1), and for those with > or =16 (=median) dissected thoracic lymph nodes (25 versus 12 months) (p<0.05*). Patients with regional lymph-node involvement (pN1) were seen to have a significant prognostic advantage in cases with more than 16 (=median), rather than less than 16 mediastinal lymph nodes resected (p=0.045*).
CONCLUSION: The prognosis in patients with squamous cell carcinoma of the esophagus is influenced by the number of dissected mediastinal lymph nodes. Patients with regional lymph-node involvement appear to benefit from an extended lymphadenectomy, in spite of the higher rate of complications and mortality associated with this procedure.

Entities:  

Mesh:

Year:  2006        PMID: 16720090     DOI: 10.1016/j.ejso.2006.03.048

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Clinical impact of lymphadenectomy extent in resectable esophageal cancer.

Authors:  Roderich E Schwarz; David D Smith
Journal:  J Gastrointest Surg       Date:  2007-09-02       Impact factor: 3.452

2.  Robot-assisted mediastinoscopic esophagectomy for esophageal cancer: the first clinical series.

Authors:  Masaya Nakauchi; Ichiro Uyama; Koichi Suda; Susumu Shibasaki; Kenji Kikuchi; Shinichi Kadoya; Yoshinori Ishida; Kazuki Inaba
Journal:  Esophagus       Date:  2018-08-03       Impact factor: 4.230

3.  Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.

Authors:  Ines Gockel; Carl C Schimanski; Christian Heinrich; T Wehler; K Frerichs; Daniel Drescher; Christian von Langsdorff; Mario Domeyer; Stefan Biesterfeld; Peter R Galle; Theodor Junginger; Markus Moehler
Journal:  BMC Cancer       Date:  2006-12-18       Impact factor: 4.430

4.  Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery.

Authors:  K Mori; Y Yamagata; S Aikou; M Nishida; T Kiyokawa; K Yagi; H Yamashita; S Nomura; Y Seto
Journal:  Dis Esophagus       Date:  2015-03-23       Impact factor: 3.429

5.  Transthoracic versus transhiatal esophagectomy - influence on patient survival.

Authors:  Mariusz Łochowski; Barbara Łochowska; Józef Kozak
Journal:  Prz Gastroenterol       Date:  2016-12-16

6.  TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?

Authors:  Felipe Monge Vieira; Marcio Fernandes Chedid; Richard Ricachenevsky Gurski; Carlos Cauduro Schirmer; Leandro Totti Cavazzola; Ricardo Vitiello Schramm; André Ricardo Pereira Rosa; Cleber Dario Pinto Kruel
Journal:  Arq Bras Cir Dig       Date:  2021-03-22

7.  Minimally invasive transhiatal and transthoracic esophagectomy.

Authors:  T Böttger; A Terzic; M Müller; A Rodehorst
Journal:  Surg Endosc       Date:  2007-05-04       Impact factor: 3.453

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.